Clinical Trial Update: A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pertuzumab plus trastuzumab with vinorelbine vs placebo plus trastuzumab with docetaxel in previously untreated HER2-positive metastat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: iOMEDICO AG | Conditions: Advanced Breast Cancer, HER2-positive Breast Cancer | Phase 3 | Status: WITHDRAWN